nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—PPARG—stomach cancer	0.483	1	CbGaD
Bezafibrate—SLCO1B1—Irinotecan—stomach cancer	0.0637	0.43	CbGbCtD
Bezafibrate—SLCO1B1—Methotrexate—stomach cancer	0.0337	0.227	CbGbCtD
Bezafibrate—CYP2C8—Fluorouracil—stomach cancer	0.0259	0.175	CbGbCtD
Bezafibrate—CYP3A4—Irinotecan—stomach cancer	0.0109	0.0738	CbGbCtD
Bezafibrate—CYP3A4—Docetaxel—stomach cancer	0.00802	0.0541	CbGbCtD
Bezafibrate—CYP3A4—Doxorubicin—stomach cancer	0.00598	0.0403	CbGbCtD
Bezafibrate—PPARA—blood vessel—stomach cancer	0.00514	0.0639	CbGeAlD
Bezafibrate—PPARG—Topotecan—Irinotecan—stomach cancer	0.00387	1	CbGdCrCtD
Bezafibrate—HMGCR—gall bladder—stomach cancer	0.00322	0.04	CbGeAlD
Bezafibrate—PPARD—hematopoietic system—stomach cancer	0.00321	0.0399	CbGeAlD
Bezafibrate—PPARG—blood vessel—stomach cancer	0.00283	0.0352	CbGeAlD
Bezafibrate—PPARA—hematopoietic system—stomach cancer	0.00274	0.034	CbGeAlD
Bezafibrate—PPARD—pancreas—stomach cancer	0.00262	0.0325	CbGeAlD
Bezafibrate—PPARA—epithelium—stomach cancer	0.0025	0.0311	CbGeAlD
Bezafibrate—PPARA—smooth muscle tissue—stomach cancer	0.00241	0.03	CbGeAlD
Bezafibrate—PPARD—lymphoid tissue—stomach cancer	0.00226	0.0281	CbGeAlD
Bezafibrate—PPARD—digestive system—stomach cancer	0.00224	0.0278	CbGeAlD
Bezafibrate—PPARA—pancreas—stomach cancer	0.00223	0.0277	CbGeAlD
Bezafibrate—PPARA—lymphoid tissue—stomach cancer	0.00193	0.024	CbGeAlD
Bezafibrate—PPARA—digestive system—stomach cancer	0.0019	0.0237	CbGeAlD
Bezafibrate—PPARD—endocrine gland—stomach cancer	0.00185	0.023	CbGeAlD
Bezafibrate—HMGCR—hematopoietic system—stomach cancer	0.00182	0.0227	CbGeAlD
Bezafibrate—SLCO1B1—hematopoietic system—stomach cancer	0.00175	0.0217	CbGeAlD
Bezafibrate—HMGCR—epithelium—stomach cancer	0.00167	0.0207	CbGeAlD
Bezafibrate—PPARD—liver—stomach cancer	0.00167	0.0207	CbGeAlD
Bezafibrate—HMGCR—smooth muscle tissue—stomach cancer	0.00161	0.02	CbGeAlD
Bezafibrate—PPARA—endocrine gland—stomach cancer	0.00157	0.0196	CbGeAlD
Bezafibrate—PPARG—hematopoietic system—stomach cancer	0.00151	0.0187	CbGeAlD
Bezafibrate—HMGCR—pancreas—stomach cancer	0.00148	0.0184	CbGeAlD
Bezafibrate—PPARA—liver—stomach cancer	0.00142	0.0176	CbGeAlD
Bezafibrate—Balsalazide—ALOX5—stomach cancer	0.0014	0.24	CrCbGaD
Bezafibrate—PPARG—epithelium—stomach cancer	0.00138	0.0171	CbGeAlD
Bezafibrate—PPARG—smooth muscle tissue—stomach cancer	0.00133	0.0165	CbGeAlD
Bezafibrate—HMGCR—lymphoid tissue—stomach cancer	0.00128	0.0159	CbGeAlD
Bezafibrate—PPARD—lymph node—stomach cancer	0.00128	0.0159	CbGeAlD
Bezafibrate—HMGCR—digestive system—stomach cancer	0.00127	0.0158	CbGeAlD
Bezafibrate—PPARG—pancreas—stomach cancer	0.00123	0.0152	CbGeAlD
Bezafibrate—SLCO1B1—digestive system—stomach cancer	0.00121	0.0151	CbGeAlD
Bezafibrate—HMGCR—bone marrow—stomach cancer	0.00117	0.0145	CbGeAlD
Bezafibrate—PPARA—lymph node—stomach cancer	0.00109	0.0135	CbGeAlD
Bezafibrate—PPARG—lymphoid tissue—stomach cancer	0.00106	0.0132	CbGeAlD
Bezafibrate—HMGCR—endocrine gland—stomach cancer	0.00105	0.013	CbGeAlD
Bezafibrate—PPARG—digestive system—stomach cancer	0.00105	0.013	CbGeAlD
Bezafibrate—SLCO1B1—endocrine gland—stomach cancer	0.001	0.0125	CbGeAlD
Bezafibrate—CYP2C8—hematopoietic system—stomach cancer	0.000993	0.0123	CbGeAlD
Bezafibrate—PPARG—bone marrow—stomach cancer	0.000966	0.012	CbGeAlD
Bezafibrate—HMGCR—liver—stomach cancer	0.000944	0.0117	CbGeAlD
Bezafibrate—CYP1A1—hematopoietic system—stomach cancer	0.000917	0.0114	CbGeAlD
Bezafibrate—SLCO1B1—liver—stomach cancer	0.000905	0.0112	CbGeAlD
Bezafibrate—PPARG—endocrine gland—stomach cancer	0.000866	0.0108	CbGeAlD
Bezafibrate—Indomethacin—AKR1C3—stomach cancer	0.000853	0.146	CrCbGaD
Bezafibrate—CYP1A1—epithelium—stomach cancer	0.000838	0.0104	CbGeAlD
Bezafibrate—Balsalazide—PPARG—stomach cancer	0.000803	0.137	CrCbGaD
Bezafibrate—PPARG—liver—stomach cancer	0.00078	0.0097	CbGeAlD
Bezafibrate—HMGCR—lymph node—stomach cancer	0.000724	0.009	CbGeAlD
Bezafibrate—CYP3A4—hematopoietic system—stomach cancer	0.000673	0.00836	CbGeAlD
Bezafibrate—CYP1A1—digestive system—stomach cancer	0.000637	0.00792	CbGeAlD
Bezafibrate—Clofibrate—CYP2A6—stomach cancer	0.000631	0.108	CrCbGaD
Bezafibrate—PPARG—lymph node—stomach cancer	0.000598	0.00744	CbGeAlD
Bezafibrate—CYP2C8—endocrine gland—stomach cancer	0.000571	0.00709	CbGeAlD
Bezafibrate—Ritodrine—ADRB2—stomach cancer	0.000557	0.0951	CrCbGaD
Bezafibrate—CYP1A1—endocrine gland—stomach cancer	0.000527	0.00655	CbGeAlD
Bezafibrate—CYP2C8—liver—stomach cancer	0.000514	0.00639	CbGeAlD
Bezafibrate—Indomethacin—CXCL8—stomach cancer	0.000512	0.0875	CrCbGaD
Bezafibrate—Headache—Mitomycin—stomach cancer	0.000487	0.0044	CcSEcCtD
Bezafibrate—Purpura—Capecitabine—stomach cancer	0.000477	0.00431	CcSEcCtD
Bezafibrate—CYP1A1—liver—stomach cancer	0.000475	0.0059	CbGeAlD
Bezafibrate—CYP3A4—digestive system—stomach cancer	0.000468	0.00581	CbGeAlD
Bezafibrate—Migraine—Docetaxel—stomach cancer	0.000467	0.00422	CcSEcCtD
Bezafibrate—Nausea—Mitomycin—stomach cancer	0.000462	0.00417	CcSEcCtD
Bezafibrate—Migraine—Capecitabine—stomach cancer	0.000453	0.00408	CcSEcCtD
Bezafibrate—Pharyngitis—Fluorouracil—stomach cancer	0.000452	0.00408	CcSEcCtD
Bezafibrate—Phosphatase alkaline increased—Epirubicin—stomach cancer	0.000441	0.00398	CcSEcCtD
Bezafibrate—Liver function test abnormal—Docetaxel—stomach cancer	0.000438	0.00396	CcSEcCtD
Bezafibrate—Blood creatinine increased—Capecitabine—stomach cancer	0.000431	0.00389	CcSEcCtD
Bezafibrate—Cramp muscle—Docetaxel—stomach cancer	0.000428	0.00386	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Docetaxel—stomach cancer	0.000428	0.00386	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Docetaxel—stomach cancer	0.000428	0.00386	CcSEcCtD
Bezafibrate—Liver function test abnormal—Capecitabine—stomach cancer	0.000425	0.00383	CcSEcCtD
Bezafibrate—Alopecia—Irinotecan—stomach cancer	0.00042	0.00379	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Docetaxel—stomach cancer	0.000419	0.00378	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Capecitabine—stomach cancer	0.000414	0.00374	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Capecitabine—stomach cancer	0.000414	0.00374	CcSEcCtD
Bezafibrate—Phosphatase alkaline increased—Doxorubicin—stomach cancer	0.000408	0.00369	CcSEcCtD
Bezafibrate—Flatulence—Irinotecan—stomach cancer	0.000408	0.00368	CcSEcCtD
Bezafibrate—Gastritis—Capecitabine—stomach cancer	0.000407	0.00367	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Capecitabine—stomach cancer	0.000406	0.00366	CcSEcCtD
Bezafibrate—Muscular weakness—Capecitabine—stomach cancer	0.000406	0.00366	CcSEcCtD
Bezafibrate—Alopecia—Fluorouracil—stomach cancer	0.000402	0.00363	CcSEcCtD
Bezafibrate—Muscle spasms—Irinotecan—stomach cancer	0.000398	0.00359	CcSEcCtD
Bezafibrate—Influenza—Capecitabine—stomach cancer	0.000397	0.00359	CcSEcCtD
Bezafibrate—Erythema—Fluorouracil—stomach cancer	0.000396	0.00358	CcSEcCtD
Bezafibrate—Photosensitivity—Methotrexate—stomach cancer	0.00039	0.00352	CcSEcCtD
Bezafibrate—Pancytopenia—Docetaxel—stomach cancer	0.00039	0.00352	CcSEcCtD
Bezafibrate—CYP3A4—endocrine gland—stomach cancer	0.000386	0.0048	CbGeAlD
Bezafibrate—Anaemia—Irinotecan—stomach cancer	0.000382	0.00345	CcSEcCtD
Bezafibrate—Bronchitis—Capecitabine—stomach cancer	0.000382	0.00345	CcSEcCtD
Bezafibrate—Pancytopenia—Capecitabine—stomach cancer	0.000377	0.00341	CcSEcCtD
Bezafibrate—Renal failure acute—Methotrexate—stomach cancer	0.000371	0.00335	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Epirubicin—stomach cancer	0.000368	0.00332	CcSEcCtD
Bezafibrate—Anaemia—Fluorouracil—stomach cancer	0.000366	0.00331	CcSEcCtD
Bezafibrate—Photosensitivity—Epirubicin—stomach cancer	0.000365	0.00329	CcSEcCtD
Bezafibrate—CYP1A1—lymph node—stomach cancer	0.000364	0.00452	CbGeAlD
Bezafibrate—Stevens-Johnson syndrome—Docetaxel—stomach cancer	0.000363	0.00327	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Capecitabine—stomach cancer	0.000363	0.00327	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Docetaxel—stomach cancer	0.000361	0.00326	CcSEcCtD
Bezafibrate—Myocardial infarction—Docetaxel—stomach cancer	0.000359	0.00324	CcSEcCtD
Bezafibrate—Vascular purpura—Epirubicin—stomach cancer	0.000358	0.00323	CcSEcCtD
Bezafibrate—Eczema—Epirubicin—stomach cancer	0.000356	0.00322	CcSEcCtD
Bezafibrate—Indomethacin—PPARG—stomach cancer	0.000354	0.0605	CrCbGaD
Bezafibrate—Stevens-Johnson syndrome—Capecitabine—stomach cancer	0.000351	0.00317	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Capecitabine—stomach cancer	0.000349	0.00315	CcSEcCtD
Bezafibrate—CYP3A4—liver—stomach cancer	0.000348	0.00433	CbGeAlD
Bezafibrate—Myocardial infarction—Capecitabine—stomach cancer	0.000347	0.00313	CcSEcCtD
Bezafibrate—Renal failure acute—Epirubicin—stomach cancer	0.000347	0.00313	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Doxorubicin—stomach cancer	0.000341	0.00308	CcSEcCtD
Bezafibrate—Balsalazide—PTGS2—stomach cancer	0.000339	0.0579	CrCbGaD
Bezafibrate—Photosensitivity—Doxorubicin—stomach cancer	0.000338	0.00305	CcSEcCtD
Bezafibrate—Myalgia—Fluorouracil—stomach cancer	0.000337	0.00304	CcSEcCtD
Bezafibrate—Infection—Irinotecan—stomach cancer	0.000335	0.00303	CcSEcCtD
Bezafibrate—Purpura—Epirubicin—stomach cancer	0.000332	0.003	CcSEcCtD
Bezafibrate—Vascular purpura—Doxorubicin—stomach cancer	0.000331	0.00299	CcSEcCtD
Bezafibrate—Thrombocytopenia—Irinotecan—stomach cancer	0.000331	0.00298	CcSEcCtD
Bezafibrate—Eczema—Doxorubicin—stomach cancer	0.00033	0.00298	CcSEcCtD
Bezafibrate—Pharyngitis—Docetaxel—stomach cancer	0.000326	0.00294	CcSEcCtD
Bezafibrate—Urinary tract disorder—Docetaxel—stomach cancer	0.000324	0.00293	CcSEcCtD
Bezafibrate—Urethral disorder—Docetaxel—stomach cancer	0.000322	0.00291	CcSEcCtD
Bezafibrate—Infection—Fluorouracil—stomach cancer	0.000321	0.0029	CcSEcCtD
Bezafibrate—Renal failure acute—Doxorubicin—stomach cancer	0.000321	0.0029	CcSEcCtD
Bezafibrate—Thrombocytopenia—Fluorouracil—stomach cancer	0.000317	0.00286	CcSEcCtD
Bezafibrate—Liver function test abnormal—Methotrexate—stomach cancer	0.000316	0.00285	CcSEcCtD
Bezafibrate—Pharyngitis—Capecitabine—stomach cancer	0.000316	0.00285	CcSEcCtD
Bezafibrate—Migraine—Epirubicin—stomach cancer	0.000315	0.00285	CcSEcCtD
Bezafibrate—Urinary tract disorder—Capecitabine—stomach cancer	0.000314	0.00284	CcSEcCtD
Bezafibrate—Urethral disorder—Capecitabine—stomach cancer	0.000312	0.00281	CcSEcCtD
Bezafibrate—Erythema multiforme—Docetaxel—stomach cancer	0.000311	0.0028	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Methotrexate—stomach cancer	0.000308	0.00278	CcSEcCtD
Bezafibrate—Purpura—Doxorubicin—stomach cancer	0.000308	0.00278	CcSEcCtD
Bezafibrate—Insomnia—Irinotecan—stomach cancer	0.000305	0.00276	CcSEcCtD
Bezafibrate—Erythema multiforme—Capecitabine—stomach cancer	0.000301	0.00271	CcSEcCtD
Bezafibrate—Blood creatinine increased—Epirubicin—stomach cancer	0.0003	0.00271	CcSEcCtD
Bezafibrate—Dyspepsia—Irinotecan—stomach cancer	0.000297	0.00268	CcSEcCtD
Bezafibrate—Liver function test abnormal—Epirubicin—stomach cancer	0.000296	0.00267	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000295	0.00266	CcSEcCtD
Bezafibrate—Insomnia—Fluorouracil—stomach cancer	0.000293	0.00264	CcSEcCtD
Bezafibrate—Migraine—Doxorubicin—stomach cancer	0.000292	0.00263	CcSEcCtD
Bezafibrate—Alopecia—Docetaxel—stomach cancer	0.00029	0.00262	CcSEcCtD
Bezafibrate—Constipation—Irinotecan—stomach cancer	0.000289	0.00261	CcSEcCtD
Bezafibrate—Pain—Irinotecan—stomach cancer	0.000289	0.00261	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Epirubicin—stomach cancer	0.000288	0.0026	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Epirubicin—stomach cancer	0.000288	0.0026	CcSEcCtD
Bezafibrate—Erythema—Docetaxel—stomach cancer	0.000286	0.00258	CcSEcCtD
Bezafibrate—Dyspepsia—Fluorouracil—stomach cancer	0.000285	0.00257	CcSEcCtD
Bezafibrate—Gastritis—Epirubicin—stomach cancer	0.000283	0.00256	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Epirubicin—stomach cancer	0.000283	0.00255	CcSEcCtD
Bezafibrate—Muscular weakness—Epirubicin—stomach cancer	0.000283	0.00255	CcSEcCtD
Bezafibrate—Alopecia—Capecitabine—stomach cancer	0.000281	0.00254	CcSEcCtD
Bezafibrate—Pancytopenia—Methotrexate—stomach cancer	0.000281	0.00254	CcSEcCtD
Bezafibrate—Blood creatinine increased—Doxorubicin—stomach cancer	0.000278	0.00251	CcSEcCtD
Bezafibrate—Erythema—Capecitabine—stomach cancer	0.000277	0.0025	CcSEcCtD
Bezafibrate—Influenza—Epirubicin—stomach cancer	0.000277	0.0025	CcSEcCtD
Bezafibrate—Pain—Fluorouracil—stomach cancer	0.000277	0.0025	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Irinotecan—stomach cancer	0.000276	0.00249	CcSEcCtD
Bezafibrate—Muscle spasms—Docetaxel—stomach cancer	0.000275	0.00248	CcSEcCtD
Bezafibrate—Liver function test abnormal—Doxorubicin—stomach cancer	0.000274	0.00247	CcSEcCtD
Bezafibrate—Flatulence—Capecitabine—stomach cancer	0.000273	0.00246	CcSEcCtD
Bezafibrate—Erectile dysfunction—Methotrexate—stomach cancer	0.000272	0.00246	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Methotrexate—stomach cancer	0.00027	0.00244	CcSEcCtD
Bezafibrate—Abdominal pain—Irinotecan—stomach cancer	0.000267	0.00241	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Doxorubicin—stomach cancer	0.000267	0.00241	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Doxorubicin—stomach cancer	0.000267	0.00241	CcSEcCtD
Bezafibrate—Bronchitis—Epirubicin—stomach cancer	0.000266	0.0024	CcSEcCtD
Bezafibrate—Muscle spasms—Capecitabine—stomach cancer	0.000266	0.0024	CcSEcCtD
Bezafibrate—Anaemia—Docetaxel—stomach cancer	0.000264	0.00239	CcSEcCtD
Bezafibrate—Pancytopenia—Epirubicin—stomach cancer	0.000263	0.00237	CcSEcCtD
Bezafibrate—Gastritis—Doxorubicin—stomach cancer	0.000262	0.00237	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.000262	0.00236	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Doxorubicin—stomach cancer	0.000261	0.00236	CcSEcCtD
Bezafibrate—Muscular weakness—Doxorubicin—stomach cancer	0.000261	0.00236	CcSEcCtD
Bezafibrate—Urticaria—Fluorouracil—stomach cancer	0.000257	0.00232	CcSEcCtD
Bezafibrate—Influenza—Doxorubicin—stomach cancer	0.000256	0.00231	CcSEcCtD
Bezafibrate—Anaemia—Capecitabine—stomach cancer	0.000256	0.00231	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Epirubicin—stomach cancer	0.000253	0.00228	CcSEcCtD
Bezafibrate—Hypersensitivity—Irinotecan—stomach cancer	0.000249	0.00225	CcSEcCtD
Bezafibrate—Bronchitis—Doxorubicin—stomach cancer	0.000246	0.00222	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.000245	0.00221	CcSEcCtD
Bezafibrate—Myalgia—Docetaxel—stomach cancer	0.000243	0.0022	CcSEcCtD
Bezafibrate—Pancytopenia—Doxorubicin—stomach cancer	0.000243	0.0022	CcSEcCtD
Bezafibrate—Hypersensitivity—Fluorouracil—stomach cancer	0.000238	0.00215	CcSEcCtD
Bezafibrate—Myalgia—Capecitabine—stomach cancer	0.000236	0.00213	CcSEcCtD
Bezafibrate—Pharyngitis—Methotrexate—stomach cancer	0.000235	0.00212	CcSEcCtD
Bezafibrate—Urinary tract disorder—Methotrexate—stomach cancer	0.000234	0.00211	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Doxorubicin—stomach cancer	0.000234	0.00211	CcSEcCtD
Bezafibrate—Urethral disorder—Methotrexate—stomach cancer	0.000232	0.00209	CcSEcCtD
Bezafibrate—Infection—Docetaxel—stomach cancer	0.000232	0.00209	CcSEcCtD
Bezafibrate—Diarrhoea—Irinotecan—stomach cancer	0.000231	0.00209	CcSEcCtD
Bezafibrate—Pruritus—Fluorouracil—stomach cancer	0.000229	0.00206	CcSEcCtD
Bezafibrate—Thrombocytopenia—Docetaxel—stomach cancer	0.000229	0.00206	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000226	0.00204	CcSEcCtD
Bezafibrate—Infection—Capecitabine—stomach cancer	0.000225	0.00203	CcSEcCtD
Bezafibrate—Erythema multiforme—Methotrexate—stomach cancer	0.000224	0.00202	CcSEcCtD
Bezafibrate—Dizziness—Irinotecan—stomach cancer	0.000223	0.00202	CcSEcCtD
Bezafibrate—Diarrhoea—Fluorouracil—stomach cancer	0.000221	0.002	CcSEcCtD
Bezafibrate—Thrombocytopenia—Capecitabine—stomach cancer	0.000221	0.002	CcSEcCtD
Bezafibrate—Pharyngitis—Epirubicin—stomach cancer	0.00022	0.00198	CcSEcCtD
Bezafibrate—Urinary tract disorder—Epirubicin—stomach cancer	0.000219	0.00198	CcSEcCtD
Bezafibrate—Urethral disorder—Epirubicin—stomach cancer	0.000217	0.00196	CcSEcCtD
Bezafibrate—Dizziness—Fluorouracil—stomach cancer	0.000214	0.00193	CcSEcCtD
Bezafibrate—Rash—Irinotecan—stomach cancer	0.000213	0.00192	CcSEcCtD
Bezafibrate—Dermatitis—Irinotecan—stomach cancer	0.000213	0.00192	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000213	0.00192	CcSEcCtD
Bezafibrate—Headache—Irinotecan—stomach cancer	0.000212	0.00191	CcSEcCtD
Bezafibrate—Insomnia—Docetaxel—stomach cancer	0.000211	0.00191	CcSEcCtD
Bezafibrate—Erythema multiforme—Epirubicin—stomach cancer	0.00021	0.00189	CcSEcCtD
Bezafibrate—Alopecia—Methotrexate—stomach cancer	0.000209	0.00189	CcSEcCtD
Bezafibrate—Erythema—Methotrexate—stomach cancer	0.000206	0.00186	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000206	0.00186	CcSEcCtD
Bezafibrate—Dyspepsia—Docetaxel—stomach cancer	0.000205	0.00185	CcSEcCtD
Bezafibrate—Insomnia—Capecitabine—stomach cancer	0.000204	0.00184	CcSEcCtD
Bezafibrate—Rash—Fluorouracil—stomach cancer	0.000204	0.00184	CcSEcCtD
Bezafibrate—Dermatitis—Fluorouracil—stomach cancer	0.000204	0.00184	CcSEcCtD
Bezafibrate—Pharyngitis—Doxorubicin—stomach cancer	0.000204	0.00184	CcSEcCtD
Bezafibrate—Headache—Fluorouracil—stomach cancer	0.000203	0.00183	CcSEcCtD
Bezafibrate—Urinary tract disorder—Doxorubicin—stomach cancer	0.000202	0.00183	CcSEcCtD
Bezafibrate—Urethral disorder—Doxorubicin—stomach cancer	0.000201	0.00181	CcSEcCtD
Bezafibrate—Nausea—Irinotecan—stomach cancer	0.000201	0.00181	CcSEcCtD
Bezafibrate—Constipation—Docetaxel—stomach cancer	0.0002	0.0018	CcSEcCtD
Bezafibrate—Pain—Docetaxel—stomach cancer	0.0002	0.0018	CcSEcCtD
Bezafibrate—Dyspepsia—Capecitabine—stomach cancer	0.000199	0.0018	CcSEcCtD
Bezafibrate—Alopecia—Epirubicin—stomach cancer	0.000196	0.00177	CcSEcCtD
Bezafibrate—Erythema multiforme—Doxorubicin—stomach cancer	0.000194	0.00175	CcSEcCtD
Bezafibrate—Pain—Capecitabine—stomach cancer	0.000193	0.00174	CcSEcCtD
Bezafibrate—Constipation—Capecitabine—stomach cancer	0.000193	0.00174	CcSEcCtD
Bezafibrate—Erythema—Epirubicin—stomach cancer	0.000193	0.00174	CcSEcCtD
Bezafibrate—Nausea—Fluorouracil—stomach cancer	0.000192	0.00173	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Docetaxel—stomach cancer	0.000191	0.00172	CcSEcCtD
Bezafibrate—Anaemia—Methotrexate—stomach cancer	0.000191	0.00172	CcSEcCtD
Bezafibrate—Flatulence—Epirubicin—stomach cancer	0.00019	0.00172	CcSEcCtD
Bezafibrate—Muscle spasms—Epirubicin—stomach cancer	0.000185	0.00167	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Capecitabine—stomach cancer	0.000185	0.00167	CcSEcCtD
Bezafibrate—Abdominal pain—Docetaxel—stomach cancer	0.000185	0.00167	CcSEcCtD
Bezafibrate—Alopecia—Doxorubicin—stomach cancer	0.000181	0.00164	CcSEcCtD
Bezafibrate—Urticaria—Capecitabine—stomach cancer	0.00018	0.00162	CcSEcCtD
Bezafibrate—Abdominal pain—Capecitabine—stomach cancer	0.000179	0.00161	CcSEcCtD
Bezafibrate—Erythema—Doxorubicin—stomach cancer	0.000178	0.00161	CcSEcCtD
Bezafibrate—Anaemia—Epirubicin—stomach cancer	0.000178	0.00161	CcSEcCtD
Bezafibrate—Flatulence—Doxorubicin—stomach cancer	0.000176	0.00159	CcSEcCtD
Bezafibrate—Myalgia—Methotrexate—stomach cancer	0.000175	0.00158	CcSEcCtD
Bezafibrate—Hypersensitivity—Docetaxel—stomach cancer	0.000172	0.00155	CcSEcCtD
Bezafibrate—Muscle spasms—Doxorubicin—stomach cancer	0.000172	0.00155	CcSEcCtD
Bezafibrate—Infection—Methotrexate—stomach cancer	0.000167	0.00151	CcSEcCtD
Bezafibrate—Hypersensitivity—Capecitabine—stomach cancer	0.000167	0.0015	CcSEcCtD
Bezafibrate—Pruritus—Docetaxel—stomach cancer	0.000165	0.00149	CcSEcCtD
Bezafibrate—Anaemia—Doxorubicin—stomach cancer	0.000165	0.00149	CcSEcCtD
Bezafibrate—Thrombocytopenia—Methotrexate—stomach cancer	0.000165	0.00149	CcSEcCtD
Bezafibrate—Myalgia—Epirubicin—stomach cancer	0.000164	0.00148	CcSEcCtD
Bezafibrate—Pruritus—Capecitabine—stomach cancer	0.00016	0.00144	CcSEcCtD
Bezafibrate—Diarrhoea—Docetaxel—stomach cancer	0.00016	0.00144	CcSEcCtD
Bezafibrate—Infection—Epirubicin—stomach cancer	0.000156	0.00141	CcSEcCtD
Bezafibrate—Diarrhoea—Capecitabine—stomach cancer	0.000155	0.0014	CcSEcCtD
Bezafibrate—Dizziness—Docetaxel—stomach cancer	0.000154	0.00139	CcSEcCtD
Bezafibrate—Thrombocytopenia—Epirubicin—stomach cancer	0.000154	0.00139	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000153	0.00138	CcSEcCtD
Bezafibrate—Insomnia—Methotrexate—stomach cancer	0.000152	0.00137	CcSEcCtD
Bezafibrate—Myalgia—Doxorubicin—stomach cancer	0.000152	0.00137	CcSEcCtD
Bezafibrate—Indomethacin—PTGS2—stomach cancer	0.000149	0.0255	CrCbGaD
Bezafibrate—Dizziness—Capecitabine—stomach cancer	0.000149	0.00135	CcSEcCtD
Bezafibrate—Dyspepsia—Methotrexate—stomach cancer	0.000148	0.00134	CcSEcCtD
Bezafibrate—Rash—Docetaxel—stomach cancer	0.000147	0.00133	CcSEcCtD
Bezafibrate—Dermatitis—Docetaxel—stomach cancer	0.000147	0.00133	CcSEcCtD
Bezafibrate—Headache—Docetaxel—stomach cancer	0.000146	0.00132	CcSEcCtD
Bezafibrate—Infection—Doxorubicin—stomach cancer	0.000145	0.00131	CcSEcCtD
Bezafibrate—Pain—Methotrexate—stomach cancer	0.000144	0.0013	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000143	0.00129	CcSEcCtD
Bezafibrate—Thrombocytopenia—Doxorubicin—stomach cancer	0.000143	0.00129	CcSEcCtD
Bezafibrate—Rash—Capecitabine—stomach cancer	0.000142	0.00129	CcSEcCtD
Bezafibrate—Insomnia—Epirubicin—stomach cancer	0.000142	0.00129	CcSEcCtD
Bezafibrate—Dermatitis—Capecitabine—stomach cancer	0.000142	0.00128	CcSEcCtD
Bezafibrate—Headache—Capecitabine—stomach cancer	0.000142	0.00128	CcSEcCtD
Bezafibrate—Nausea—Docetaxel—stomach cancer	0.000139	0.00125	CcSEcCtD
Bezafibrate—Dyspepsia—Epirubicin—stomach cancer	0.000139	0.00125	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Methotrexate—stomach cancer	0.000138	0.00124	CcSEcCtD
Bezafibrate—Pain—Epirubicin—stomach cancer	0.000135	0.00122	CcSEcCtD
Bezafibrate—Constipation—Epirubicin—stomach cancer	0.000135	0.00122	CcSEcCtD
Bezafibrate—Nausea—Capecitabine—stomach cancer	0.000134	0.00121	CcSEcCtD
Bezafibrate—Urticaria—Methotrexate—stomach cancer	0.000134	0.00121	CcSEcCtD
Bezafibrate—Indomethacin—ALB—stomach cancer	0.000133	0.0227	CrCbGaD
Bezafibrate—Abdominal pain—Methotrexate—stomach cancer	0.000133	0.0012	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000133	0.0012	CcSEcCtD
Bezafibrate—Insomnia—Doxorubicin—stomach cancer	0.000132	0.00119	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Epirubicin—stomach cancer	0.000129	0.00116	CcSEcCtD
Bezafibrate—Dyspepsia—Doxorubicin—stomach cancer	0.000128	0.00116	CcSEcCtD
Bezafibrate—Urticaria—Epirubicin—stomach cancer	0.000125	0.00113	CcSEcCtD
Bezafibrate—Pain—Doxorubicin—stomach cancer	0.000125	0.00112	CcSEcCtD
Bezafibrate—Constipation—Doxorubicin—stomach cancer	0.000125	0.00112	CcSEcCtD
Bezafibrate—Abdominal pain—Epirubicin—stomach cancer	0.000124	0.00112	CcSEcCtD
Bezafibrate—Hypersensitivity—Methotrexate—stomach cancer	0.000124	0.00112	CcSEcCtD
Bezafibrate—Glyburide—ALB—stomach cancer	0.00012	0.0205	CrCbGaD
Bezafibrate—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000119	0.00108	CcSEcCtD
Bezafibrate—Pruritus—Methotrexate—stomach cancer	0.000119	0.00107	CcSEcCtD
Bezafibrate—Hypersensitivity—Epirubicin—stomach cancer	0.000116	0.00105	CcSEcCtD
Bezafibrate—Urticaria—Doxorubicin—stomach cancer	0.000116	0.00104	CcSEcCtD
Bezafibrate—Abdominal pain—Doxorubicin—stomach cancer	0.000115	0.00104	CcSEcCtD
Bezafibrate—Diarrhoea—Methotrexate—stomach cancer	0.000115	0.00104	CcSEcCtD
Bezafibrate—Pruritus—Epirubicin—stomach cancer	0.000111	0.00101	CcSEcCtD
Bezafibrate—Dizziness—Methotrexate—stomach cancer	0.000111	0.001	CcSEcCtD
Bezafibrate—Diarrhoea—Epirubicin—stomach cancer	0.000108	0.000972	CcSEcCtD
Bezafibrate—Hypersensitivity—Doxorubicin—stomach cancer	0.000107	0.000969	CcSEcCtD
Bezafibrate—Rash—Methotrexate—stomach cancer	0.000106	0.000957	CcSEcCtD
Bezafibrate—Dermatitis—Methotrexate—stomach cancer	0.000106	0.000956	CcSEcCtD
Bezafibrate—Headache—Methotrexate—stomach cancer	0.000105	0.000951	CcSEcCtD
Bezafibrate—Dizziness—Epirubicin—stomach cancer	0.000104	0.00094	CcSEcCtD
Bezafibrate—Pruritus—Doxorubicin—stomach cancer	0.000103	0.00093	CcSEcCtD
Bezafibrate—Nausea—Methotrexate—stomach cancer	9.99e-05	0.000902	CcSEcCtD
Bezafibrate—Diarrhoea—Doxorubicin—stomach cancer	9.97e-05	0.0009	CcSEcCtD
Bezafibrate—Rash—Epirubicin—stomach cancer	9.93e-05	0.000896	CcSEcCtD
Bezafibrate—Dermatitis—Epirubicin—stomach cancer	9.92e-05	0.000895	CcSEcCtD
Bezafibrate—Headache—Epirubicin—stomach cancer	9.86e-05	0.00089	CcSEcCtD
Bezafibrate—Dizziness—Doxorubicin—stomach cancer	9.63e-05	0.000869	CcSEcCtD
Bezafibrate—Nausea—Epirubicin—stomach cancer	9.35e-05	0.000844	CcSEcCtD
Bezafibrate—Rash—Doxorubicin—stomach cancer	9.19e-05	0.000829	CcSEcCtD
Bezafibrate—Dermatitis—Doxorubicin—stomach cancer	9.18e-05	0.000828	CcSEcCtD
Bezafibrate—Headache—Doxorubicin—stomach cancer	9.13e-05	0.000824	CcSEcCtD
Bezafibrate—Nausea—Doxorubicin—stomach cancer	8.65e-05	0.000781	CcSEcCtD
Bezafibrate—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	2.2e-05	0.000131	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—MYC—stomach cancer	2.2e-05	0.000131	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—SERPINE1—stomach cancer	2.2e-05	0.000131	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—GSTP1—stomach cancer	2.2e-05	0.000131	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—AKR1C3—stomach cancer	2.18e-05	0.00013	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—HMOX1—stomach cancer	2.16e-05	0.000129	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—CAV1—stomach cancer	2.16e-05	0.000129	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—APOA1—stomach cancer	2.15e-05	0.000128	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—MAPK3—stomach cancer	2.13e-05	0.000127	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ENO1—stomach cancer	2.13e-05	0.000127	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PLIN2—stomach cancer	2.11e-05	0.000126	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—ERBB2—stomach cancer	2.1e-05	0.000125	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.09e-05	0.000125	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.08e-05	0.000124	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.08e-05	0.000124	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ERCC2—stomach cancer	2.07e-05	0.000124	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—PPP2R1A—stomach cancer	2.06e-05	0.000123	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.06e-05	0.000123	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—FBP1—stomach cancer	2.06e-05	0.000123	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NDUFA2—stomach cancer	2.06e-05	0.000123	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CKB—stomach cancer	2.06e-05	0.000123	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CA1—stomach cancer	2.06e-05	0.000123	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ALOX5—stomach cancer	2.05e-05	0.000123	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—GSTM1—stomach cancer	2.05e-05	0.000122	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CA2—stomach cancer	2.05e-05	0.000122	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—TYMS—stomach cancer	2.04e-05	0.000122	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—MAPK1—stomach cancer	2.03e-05	0.000121	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—EGFR—stomach cancer	2.03e-05	0.000121	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	2.02e-05	0.000121	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—DPYD—stomach cancer	2.02e-05	0.000121	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—GSTM1—stomach cancer	2.02e-05	0.00012	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PGAM1—stomach cancer	2e-05	0.000119	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NT5E—stomach cancer	2e-05	0.000119	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—APOA1—stomach cancer	1.98e-05	0.000118	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—MTHFR—stomach cancer	1.95e-05	0.000116	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PLIN2—stomach cancer	1.93e-05	0.000115	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—TNF—stomach cancer	1.93e-05	0.000115	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ACAD8—stomach cancer	1.92e-05	0.000115	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—SMAD4—stomach cancer	1.92e-05	0.000114	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—KRAS—stomach cancer	1.91e-05	0.000114	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALDH7A1—stomach cancer	1.91e-05	0.000114	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PLCE1—stomach cancer	1.91e-05	0.000114	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PPARG—stomach cancer	1.9e-05	0.000113	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ERCC2—stomach cancer	1.9e-05	0.000113	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CD44—stomach cancer	1.89e-05	0.000112	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CA2—stomach cancer	1.88e-05	0.000112	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—PPARG—stomach cancer	1.86e-05	0.000111	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PGAM1—stomach cancer	1.83e-05	0.000109	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NT5E—stomach cancer	1.83e-05	0.000109	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.83e-05	0.000109	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.83e-05	0.000109	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—UMPS—stomach cancer	1.83e-05	0.000109	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CAV1—stomach cancer	1.8e-05	0.000107	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MMP9—stomach cancer	1.8e-05	0.000107	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—APOA1—stomach cancer	1.79e-05	0.000107	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GSTT1—stomach cancer	1.79e-05	0.000107	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—MTHFR—stomach cancer	1.78e-05	0.000106	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYP2A6—stomach cancer	1.77e-05	0.000105	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—ERCC2—stomach cancer	1.75e-05	0.000104	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PLCE1—stomach cancer	1.75e-05	0.000104	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALDH7A1—stomach cancer	1.75e-05	0.000104	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—AKR1C3—stomach cancer	1.72e-05	0.000102	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.72e-05	0.000102	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GMPR2—stomach cancer	1.71e-05	0.000102	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—ALB—stomach cancer	1.71e-05	0.000102	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PDHA1—stomach cancer	1.7e-05	0.000101	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ECHS1—stomach cancer	1.7e-05	0.000101	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—UMPS—stomach cancer	1.68e-05	9.99e-05	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—SERPINE1—stomach cancer	1.67e-05	9.99e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ENO1—stomach cancer	1.67e-05	9.99e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.65e-05	9.82e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CAV1—stomach cancer	1.64e-05	9.81e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—APOA1—stomach cancer	1.64e-05	9.79e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—NOS3—stomach cancer	1.63e-05	9.73e-05	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—HRAS—stomach cancer	1.63e-05	9.71e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—VEGFA—stomach cancer	1.61e-05	9.63e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PPP2R1A—stomach cancer	1.6e-05	9.57e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—STAT3—stomach cancer	1.6e-05	9.53e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—TYMP—stomach cancer	1.6e-05	9.53e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—FADS1—stomach cancer	1.6e-05	9.53e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PPARG—stomach cancer	1.58e-05	9.43e-05	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—MYC—stomach cancer	1.58e-05	9.41e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GSTP1—stomach cancer	1.57e-05	9.38e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.57e-05	9.37e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—ALB—stomach cancer	1.57e-05	9.34e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—IDH3B—stomach cancer	1.57e-05	9.34e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SUCLG1—stomach cancer	1.57e-05	9.34e-05	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—IL6—stomach cancer	1.56e-05	9.29e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PDHA1—stomach cancer	1.56e-05	9.29e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ECHS1—stomach cancer	1.56e-05	9.29e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—HMOX1—stomach cancer	1.55e-05	9.25e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MAPK3—stomach cancer	1.53e-05	9.11e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SREBF2—stomach cancer	1.5e-05	8.92e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PTGS2—stomach cancer	1.49e-05	8.9e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CD44—stomach cancer	1.49e-05	8.86e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—RORA—stomach cancer	1.48e-05	8.82e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—FADS1—stomach cancer	1.46e-05	8.73e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—TYMP—stomach cancer	1.46e-05	8.73e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—TYMS—stomach cancer	1.46e-05	8.72e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NDUFS1—stomach cancer	1.46e-05	8.68e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NDUFV1—stomach cancer	1.46e-05	8.68e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MAPK1—stomach cancer	1.45e-05	8.67e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—EGFR—stomach cancer	1.45e-05	8.66e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GSTM1—stomach cancer	1.45e-05	8.62e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PPARG—stomach cancer	1.45e-05	8.62e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.44e-05	8.59e-05	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—MAPK3—stomach cancer	1.43e-05	8.53e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ALB—stomach cancer	1.42e-05	8.48e-05	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—MYC—stomach cancer	1.39e-05	8.3e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALDOB—stomach cancer	1.39e-05	8.26e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—TNF—stomach cancer	1.38e-05	8.25e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—KRAS—stomach cancer	1.37e-05	8.18e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SREBF2—stomach cancer	1.37e-05	8.18e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—NOS3—stomach cancer	1.36e-05	8.11e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ERCC2—stomach cancer	1.36e-05	8.11e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—RORA—stomach cancer	1.36e-05	8.08e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.31e-05	7.79e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.3e-05	7.77e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ALB—stomach cancer	1.3e-05	7.75e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—BLVRB—stomach cancer	1.3e-05	7.74e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PGLS—stomach cancer	1.3e-05	7.74e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALOX5—stomach cancer	1.29e-05	7.68e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—MTHFR—stomach cancer	1.28e-05	7.62e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALDOB—stomach cancer	1.27e-05	7.57e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—DPYD—stomach cancer	1.27e-05	7.56e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PPP2R1A—stomach cancer	1.26e-05	7.53e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—NOS3—stomach cancer	1.24e-05	7.42e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PTGS2—stomach cancer	1.24e-05	7.42e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GSTP1—stomach cancer	1.24e-05	7.39e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPAP2A—stomach cancer	1.24e-05	7.38e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—HMOX1—stomach cancer	1.22e-05	7.29e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—SERPINE1—stomach cancer	1.2e-05	7.16e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.2e-05	7.14e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.19e-05	7.13e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALOX5—stomach cancer	1.18e-05	7.04e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CAV1—stomach cancer	1.18e-05	7.03e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—APOA1—stomach cancer	1.18e-05	7.01e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—HRAS—stomach cancer	1.17e-05	6.96e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—DPYD—stomach cancer	1.16e-05	6.93e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—TYMS—stomach cancer	1.15e-05	6.87e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.15e-05	6.85e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GSTM1—stomach cancer	1.14e-05	6.79e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PTGS2—stomach cancer	1.14e-05	6.78e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.13e-05	6.72e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTT1—stomach cancer	1.12e-05	6.68e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—IL6—stomach cancer	1.12e-05	6.66e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP2A6—stomach cancer	1.11e-05	6.6e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NDUFA2—stomach cancer	1.1e-05	6.58e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—FBP1—stomach cancer	1.1e-05	6.58e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CKB—stomach cancer	1.1e-05	6.58e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CA1—stomach cancer	1.1e-05	6.58e-05	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—MAPK3—stomach cancer	1.09e-05	6.5e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AKR1C3—stomach cancer	1.08e-05	6.42e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ERCC2—stomach cancer	1.07e-05	6.38e-05	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—MYC—stomach cancer	1.06e-05	6.32e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.05e-05	6.28e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ENO1—stomach cancer	1.05e-05	6.26e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PLIN2—stomach cancer	1.04e-05	6.19e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.03e-05	6.16e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTT1—stomach cancer	1.03e-05	6.13e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP2A6—stomach cancer	1.02e-05	6.05e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CA2—stomach cancer	1.01e-05	6.02e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—MTHFR—stomach cancer	1.01e-05	6e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AKR1C3—stomach cancer	9.88e-06	5.89e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PGAM1—stomach cancer	9.83e-06	5.86e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NT5E—stomach cancer	9.83e-06	5.86e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ENO1—stomach cancer	9.62e-06	5.74e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	9.47e-06	5.65e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALDH7A1—stomach cancer	9.38e-06	5.59e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PLCE1—stomach cancer	9.38e-06	5.59e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ALB—stomach cancer	9.32e-06	5.56e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CD44—stomach cancer	9.31e-06	5.55e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CAV1—stomach cancer	9.28e-06	5.53e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—APOA1—stomach cancer	9.26e-06	5.52e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CA—stomach cancer	9.18e-06	5.48e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	9.03e-06	5.39e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—UMPS—stomach cancer	8.99e-06	5.36e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—NOS3—stomach cancer	8.91e-06	5.31e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	8.87e-06	5.29e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CD44—stomach cancer	8.54e-06	5.09e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ECHS1—stomach cancer	8.36e-06	4.99e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PDHA1—stomach cancer	8.36e-06	4.99e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	8.28e-06	4.94e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PPARG—stomach cancer	8.16e-06	4.87e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PTGS2—stomach cancer	8.15e-06	4.86e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PPP2R1A—stomach cancer	7.92e-06	4.72e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—FADS1—stomach cancer	7.86e-06	4.69e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—TYMP—stomach cancer	7.86e-06	4.69e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MAPK3—stomach cancer	7.81e-06	4.66e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTP1—stomach cancer	7.76e-06	4.63e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—HMOX1—stomach cancer	7.66e-06	4.57e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CA—stomach cancer	7.65e-06	4.56e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MYC—stomach cancer	7.6e-06	4.53e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SREBF2—stomach cancer	7.36e-06	4.39e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ALB—stomach cancer	7.34e-06	4.38e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—RORA—stomach cancer	7.27e-06	4.34e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PPP2R1A—stomach cancer	7.26e-06	4.33e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—TYMS—stomach cancer	7.22e-06	4.31e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTM1—stomach cancer	7.14e-06	4.26e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTP1—stomach cancer	7.12e-06	4.25e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—HMOX1—stomach cancer	7.02e-06	4.19e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—NOS3—stomach cancer	7.02e-06	4.19e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CA—stomach cancer	7e-06	4.17e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALDOB—stomach cancer	6.82e-06	4.07e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ERCC2—stomach cancer	6.71e-06	4e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—TYMS—stomach cancer	6.62e-06	3.95e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTM1—stomach cancer	6.54e-06	3.9e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PTGS2—stomach cancer	6.42e-06	3.83e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALOX5—stomach cancer	6.34e-06	3.78e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—MTHFR—stomach cancer	6.31e-06	3.76e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—DPYD—stomach cancer	6.23e-06	3.72e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ERCC2—stomach cancer	6.15e-06	3.67e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CAV1—stomach cancer	5.82e-06	3.47e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—APOA1—stomach cancer	5.8e-06	3.46e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—MTHFR—stomach cancer	5.78e-06	3.45e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.56e-06	3.31e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTT1—stomach cancer	5.51e-06	3.29e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP2A6—stomach cancer	5.45e-06	3.25e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CAV1—stomach cancer	5.33e-06	3.18e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—APOA1—stomach cancer	5.32e-06	3.17e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AKR1C3—stomach cancer	5.3e-06	3.16e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ENO1—stomach cancer	5.17e-06	3.08e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PPARG—stomach cancer	5.11e-06	3.05e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.09e-06	3.04e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CA—stomach cancer	5.01e-06	2.99e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PPARG—stomach cancer	4.69e-06	2.8e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALB—stomach cancer	4.6e-06	2.74e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CD44—stomach cancer	4.58e-06	2.73e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NOS3—stomach cancer	4.4e-06	2.62e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALB—stomach cancer	4.22e-06	2.51e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NOS3—stomach cancer	4.03e-06	2.4e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PTGS2—stomach cancer	4.02e-06	2.4e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CA—stomach cancer	3.95e-06	2.35e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPP2R1A—stomach cancer	3.9e-06	2.32e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTP1—stomach cancer	3.82e-06	2.28e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HMOX1—stomach cancer	3.77e-06	2.25e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PTGS2—stomach cancer	3.69e-06	2.2e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—TYMS—stomach cancer	3.55e-06	2.12e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTM1—stomach cancer	3.51e-06	2.09e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ERCC2—stomach cancer	3.3e-06	1.97e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—MTHFR—stomach cancer	3.1e-06	1.85e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CAV1—stomach cancer	2.86e-06	1.71e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APOA1—stomach cancer	2.86e-06	1.7e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPARG—stomach cancer	2.52e-06	1.5e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CA—stomach cancer	2.47e-06	1.48e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CA—stomach cancer	2.27e-06	1.35e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALB—stomach cancer	2.26e-06	1.35e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NOS3—stomach cancer	2.16e-06	1.29e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PTGS2—stomach cancer	1.98e-06	1.18e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.22e-06	7.26e-06	CbGpPWpGaD
